Regeneron Pharmaceuticals logo

Principal Material Sciences Engineer

Regeneron Pharmaceuticals

East Greenbush, NYOnsitePosted 2 days ago$92,200.00 - $150,600.00/year
Full TimeSenior LevelManufacturing & CMCBiotechnology
Original posting ↗

Summary

At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Principal Material Sciences Engineer to join our Drug Product Process Sciences team. This is a technical services department that deals with a range of scientific, technical, engineering and mathematical needs from the laboratory to the manufacturing floor. In this partially lab-based role you will focus on material science and provide technical support to manufacturing, quality, combination products, formulations, and CMC Regulatory for manufacturing processes from technology transfer and/or design transfer to post-commercial lifecycle management activities.

Job description

When & where

  • Location: East Greenbush, New York, United States
  • Work model: Monday-Friday, 8am-4:30pm
  • Travel percentage: 5% domestic & occasionally international

Discover your role

  • Applies materials expertise across polymer science, physics, metallurgy, ceramics, and composites, connecting structure, processing, properties, and performance to drive design, development, and life-cycle management in biomedical or biopharmaceutical environments
  • Provides technical support, guidance, and risk assessment related to materials science across technology transfer, design transfer, process control strategy, process validation lifecycle, and post-commercialization activities
  • Analyzes data and information—from development through late-stage characterization and at-scale manufacturing history—using statistics, engineering principles, and other techniques to drive insights into process performance and control
  • Applies engineering principles to develop and execute process controls and validation strategies, including support for laboratory and at-scale studies for process characterization and validation
  • Liaises with cross-functional departments (Combination Products, Manufacturing, Quality Control, Formulation Development, Advanced Therapies, Quality Assurance, and CMC Regulatory) to support process lifecycle management
  • Authors protocols, reports, and technical documents with conclusions grounded in process and product knowledge, and ensures SOPs, policies, and validation plans align with industry/regulatory expectations (e.g., ICH guidelines)
  • Supports audits/inspections and contributes to CMC sections of regulatory submissions as needed

This role requires

  • BS in Materials Science Engineering or related Engineering field and 8+ years of relevant experience
  • M.S. or Ph.D. preferred
  • A background in aseptic processing, drug substance development, drug product development, combination product development

Requirements

  • BS in Materials Science Engineering or related Engineering field
  • 8+ years of relevant experience
  • Background in aseptic processing
  • Background in drug substance development
  • Background in drug product development
  • Background in combination product development
  • M.S. or Ph.D. preferred

Benefits

  • Annual bonuses
  • Incentive plans
  • Equity awards
  • Pension or retirement benefits
  • 401(k) company match
  • Health and wellness programs
  • Fitness centers
  • Insurance benefits
  • Paid time off
  • Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.